We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




One-Week Treatment for Breast Cancer

By HospiMedica staff writers
Posted on 01 Feb 2005
A new treatment for breast cancer, called accelerated partial breast irradiation (APBI), requires only one week and has shown similar cure rates as traditional radiation treatments.

Following lumpectomy, small plastic tubes are inserted into the region of the breast that contains the tumor. More...
The patient then undergoes a series of 15-minute treatments, typically twice per day for one week, in which a wire with a radioactive source at the tip is inserted into the breast. The radiation is emitted no further than a few centimeters, killing any remaining tumor cells in the area, while minimizing the radiation dose to other healthy tissues. This shorter course would make treatment easier for people who have difficulty getting to a treatment facility every day for five to seven weeks. In addition, this technique preserves the breast.

"Research at many centers worldwide now indicates a low risk of local recurrence with APBI,” noted Dr. James R. Gray, radiation oncologist at the Sarah Cannon Cancer Center in Nashville (TN, USA).

Implant Sciences Corp. (Wakefield, MA, USA) is promoting the new treatment with the development of a lower-energy radiation source that has the potential to replace current treatments only offered in large hospitals with concrete facilities. "Our low energy source does not require an expensive concrete radiation facility and can allow small community hospitals around the country and around the world to offer APBI for all women,” commented Dr. Anthony J. Armini, CEO of Implant Sciences.




Related Links:
Implant Sciences

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.